Identify GADD45G as a potential target of 4-methoxydalbergione in treatment of liver cancer: bioinformatics analysis and in vivo experiment.

"Declarations Ethics approval and consent to participateThis study was approved by the Animal Ethics Committee of Hunan Academy of Traditional Chinese Medicine (number 2022–0025). Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding This work was supported by the National Natural Science Foundation of China (82260581); Hunan Provincial Natural Science Foundation of China (2022JJ50291); Scientific Research Foundation of Hunan Provincial Education Department (21B0907 and 22B1038); National University Students’ Innovation and Entrepreneurship Training Program (202112214004); Scientific Research Foundation of Guangxi Zhuang Autonomous Region Health Commission (Z20211512); and Hunan University of Medicine Scientific Research Incubator Construction Project (2022)."